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Introduction: Inflammatory myopathies (such as dermatomyositis and polymyositis) are well-recognized
paraneoplastic syndromes. However, paraneoplastic necrotizing myopathy is a more recently defined clinical entity,
characterized by rapidly progressive, symmetrical, predominantly proximal muscle weakness with severe disability,
and associated with a marked increase in serum muscle enzyme levels. Paraneoplastic necrotizing myopathy
requires muscle biopsy for diagnosis, which typically shows massive necrosis of muscle fibers with limited or absent
inflammatory infiltrates.
Case presentation: We report the case of an 82-year-old Italian-born Caucasian man who was admitted to hospital
because of heart failure and two drop attacks. Over the following days, he developed progressive severe weakness,
dysphagia, and dysphonia. Testing showed increasing serum muscle enzyme levels. Electromyography showed
irritative myopathy of the proximal muscles and sensorimotor polyneuropathy. Muscle biopsy (left vastus lateralis)
showed massive necrosis of muscle fibers with negligible inflammatory infiltrates, complement membrane attack
complex deposition on endomysial capillaries, and moderate upregulation of major histocompatibility complex-I.
Computed tomography of the thorax showed a nodular mass in the apex of the right lung. The patient was
diagnosed with paraneoplastic necrotizing myopathy. In spite of high-dose corticoid therapy, he died 1 month later
because of his aggressive cancer. Subsequent electron microscopic examination of a muscle biopsy specimen
showed thickened walls and typical pipestem changes of the endomysial capillaries, with swollen endothelial cells.
Poorly differentiated adenocarcinoma of the lung was confirmed on post-mortem histological examination.
Conclusions: Paraneoplastic necrotizing myopathy is a rare syndrome with outcomes ranging from fast progression
to complete recovery. Treatment with corticosteroids is often ineffective, and prognosis depends mainly on the
characteristics of the underlying cancer. This case shows that paraneoplastic necrotizing myopathy may have an
atypical appearance, and should be considered in elderly patients with neoplastic disease. In this case, the diagnosis
was delayed by the unusual clinical picture that suggested heart disease rather than muscle disease.
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Paraneoplastic necrotizing myopathy is a rare condition
associated with cancer and characterized by massive ne-
crosis of muscle fibers in the absence of significant inflam-
mation [1-11]. It is part of the distinct disease entity of
necrotizing myopathy, which has been added as an inde-
pendent new domain to idiopathic inflammatory myop-
athy [6,7]. As autoimmunity is considered to play a role in
the development of this condition, it is currently known as
necrotizing autoimmune myopathy (NAM) [12]. An asso-
ciation between myopathy and cancer has been reported
for the past century. This myopathy occurs in less than 1%
of patients with cancer, and often precedes diagnosis of
the cancer itself. Paraneoplastic necrotizing myopathy dif-
fers from primary myositis in that the prognosis is
dependent on the underlying malignancy. Diagnosis of the
underlying cancer is therefore crucial to the management
of these patients. Paraneoplastic myopathy presents with
symmetrical proximal muscle weakness, with acute or
subacute onset of other symptoms such as dysphagia.
Compared with non-neoplastic myopathy, paraneoplastic
myopathy is much more likely to be associated with a
marked increase in serum creatine kinase (CK) level and
electromyographic changes characteristic of irritative my-
opathy [1]. This condition is associated with many neo-
plasms, including gastrointestinal adenocarcinoma, non-
small cell lung carcinoma, and breast cancer.
Paraneoplastic necrotizing myopathy is diagnosed on
histological examination of biopsy specimens, and is char-
acterized by massive necrosis of muscle fibers and very
few inflammatory changes. Some cases have focal or gen-
eral capillary depletion and complement membrane attack
complex (MAC) deposition in a significant proportion of
endomysial capillaries [2,3,12]. Thickened and hyalinized
capillaries, called pipestem capillaries, are an ultrastruc-
tural finding associated with necrotizing myopathy [2,3,7]
which has also been described in paraneoplastic cases [2].
The minimal inflammatory infiltrate allows necrotizing
myopathy to be distinguished from other cancer-related
myopathies [4].
Here we report the case of a man who presented with
heart failure and elevation of serum muscle enzyme
levels; he was diagnosed with paraneoplastic necrotiz-
ing myopathy. He had a poorly differentiated lung
adenocarcinoma, which had not previously been identi-
fied. This case highlights the difficulty of diagnosing
paraneoplastic necrotizing myopathy, which may be
underreported.
Case presentation
An 82-year-old Italian-born Caucasian man was admit-
ted to hospital because of heart failure and two falls
without loss of consciousness the day before. On arrival,
he was dyspneic with an oxygen saturation of 80% onroom air. He had minor bruising on his chin and left
elbow because of the falls.
He had a past history of myocardial infarction, hyperten-
sion, and chronic atrial fibrillation. His regular medications
were diuretics, aspirin, angiotensin-converting enzyme in-
hibitors, and amiodarone. Physical examination showed
that he was tachycardic and dyspneic at rest, with cyanotic
lips. Coarse crackles were heard throughout both lung
fields. A chest X-ray showed cardiomegaly and pulmonary
edema. Arterial blood gas analysis showed pH 7.40, partial
pressure of carbon dioxide 37.2mmHg, partial pressure of
oxygen 45.9mmHg, and bicarbonate 23.4mmol/L. Electro-
cardiography showed atrial fibrillation and widespread ST
depression. Laboratory tests showed elevated serum levels
of CK (5308IU/L), myoglobin (3000ng/mL), and lactate de-
hydrogenase (81,955IU/L). Serum alanine and aspartate
aminotransferase levels were also elevated, but MB-CK
and troponin T levels were in the normal range. Echocardi-
ography showed post-ischemic dilated cardiomyopathy
resulting from his previous anteroseptal myocardial infarc-
tion. He was treated with intravenous furosemide, nitrates,
and supplemental oxygen by simple face mask. His respira-
tory status improved slightly, his heart failure resolved,
and his oxygen saturation slowly normalized. Five days
later, his serum muscle enzyme levels were still elevated
(CK >3000IU/L, myoglobin >3000ng/mL, and aldolase
47.2IU/L) and he complained of progressive muscle weak-
ness (Medical Research Council grade 2-3/5), dysphonia,
and eventually dysphagia. A neurological examination
showed symmetrical severe proximal muscle weakness
(grade 2/5 for hip flexion and extension, grade 2/5 for
shoulder abduction and elbow flexion and extension). Elec-
tromyography showed fibrillations, positive sharp waves,
and brief polyphasic motor unit potentials, mainly in
the proximal muscles, associated with sensorimotor poly-
neuropathy. Slowed latency and reduced amplitude
were detected in the tibial and sural nerves (1.8mV and
4.0μV, respectively). Motor nerve conduction velocity was
40.3m/s in the tibial nerves and 38.5m/s in the sural
nerves. Because of these clinical and biochemical signs of
myolysis, immunodiagnostic tests for inflammatory myop-
athies were performed. Antinuclear antibody was negative
by indirect immunofluorescence but was positive on
human epithelial cell type 2 cells (1:640), anti-extractable
nuclear antigen antibody (immunoblotting) was positive
for SSA and for two unknown bands (65 and 74kD), and
anti-Jo1 was negative. Tumor markers were positive
(carcinoembryonic antigen, alpha-fetoprotein, CA-125, and
CA 15–3). Testing for viral antibodies was negative (cyto-
megalovirus, herpes virus, adenovirus, Coxsackie virus, echo
virus, and hepatitis B and C virus). Complement and im-
munoglobulin levels were normal. Ten days later, a vastus
lateralis muscle biopsy was performed. Immunohistological
examination showed scattered necrotic and regenerating
Figure 2 Vastus lateralis muscle biopsy. Immunohistochemical
staining for complement membrane attack complex (MAC) on a
section adjacent to that shown in Figure 1. The necrotic fibers (*)
show MAC deposition in the membrane and cytoplasm. MAC:
immunoperoxidase staining, ×100.
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endomysial connective tissue, no perifascicular atrophy,
moderate upregulation of major histocompatibility complex
(MHC)-I with neoexpression on some non-necrotic fibers,
multifocal MAC deposition in endomysial capillaries, and
capillary loss (Figures 1, 2, 3, 4, and 5). These features were
consistent with necrotizing myopathy. Mild fiber type
grouping, suggestive of a collateral reinnervation process,
was also detected.
Total body computed tomography showed a nodular
mass in the apex of the right lung (25mm in diameter), en-
larged lymph nodes below the tracheal bifurcation, and left
lower lobe pneumonia. No metastatic lesions were found,
and there were no abdominal or cerebral abnormalities.
The patient was diagnosed with paraneoplastic necrotizing
myopathy, and corticosteroid treatment was started (pred-
nisolone 1.5mg/kg/day) together with antibiotics for pneu-
monia. There was no significant clinical improvement.
The steroids were continued and the CK level slowly de-
creased. However, his weakness did not resolve, and he
died of progressive respiratory failure 40 days after admis-
sion. Subsequent examination of resin-embedded biopsy
specimens using the transmission electron microscope
showed typical pipestem changes in the endomysial capil-
laries (thickening of the basal membrane and deposition
of amorphous material) and swollen endothelial cells
(Figures 6 and 7). Morphometric analysis of cryostat sec-
tions stained for endothelial marker CD31 confirmedFigure 1 Vastus lateralis muscle biopsy. Myopathic changes with
increased variability of muscle fiber diameter and sporadic
centralized nuclei. Necrotic fibers (*) and regenerating fibers with
basophilic cytoplasm (°). Hematoxylin and eosin staining, ×100.decreased capillary density (148.2/mm2; normal range 393±
29/mm2) (Figure 4). Post-mortem examination provided
histological confirmation of a neoplasm of the right lung
(2.5cm diameter). The tumor was a partly necrotic, poorly
differentiated adenocarcinoma that infiltrated the lung par-
enchyma, with lymph node metastases. The post-mortem
examination also revealed bilateral bronchopneumonia
(Figures 8 and 9) and myocardial sclerosis. We did not treat
our patient with chemotherapy or immunoglobulin because
he had advanced cancer at the time of diagnosis and hisFigure 3 Vastus lateralis muscle biopsy. Endomysial capillaries
with complement membrane attack complex (MAC) deposition.
MAC: immunoperoxidase staining, ×400.
Figure 4 Vastus lateralis muscle biopsy. Lowered density of
endomysial capillaries: several fibers have no capillaries in the
endomysial space (number of capillaries/mm2 of cross-sectional area:
148.2; normal value 393.2). CD31: immunoperoxidase staining, ×200.
Figure 6 Vastus lateralis muscle biopsy. Thickened endomysial
capillary wall, surrounded by a thick layer of amorphous material
including the pericytes, and collagen fibers. Transmission electron
microscopy, ×5200.
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recognition particle (SRP).
Search strategy
We searched PubMed using the terms “necrotizing my-
opathy” and “paraneoplastic necrotizing myopathy”.
Discussion
We describe a case of paraneoplastic necrotizing myopathy
in a patient with an undiagnosed lung adenocarcinoma.
The patient had a history of ischemic heart disease, and
was admitted to hospital for treatment of heart failure. His
symptoms were initially attributed to a myocardial infarc-
tion because of his clinical history and electrocardiographyFigure 5 Vastus lateralis muscle biopsy. Necrotic fibers (*) with
macrophage invasion show strong major histocompatibility complex
(MHC)-I expression. Global MHC-I upregulation is very mild, with
neoexpression on a limited subset of intact fibers (°). MHC-I:
immunoperoxidase staining, ×200.and echocardiography findings, and the elevated serum
muscle enzyme levels were attributed to myocardial ische-
mia. After admission, his heart failure resolved, but his
muscle enzyme levels continued to increase. He developed
symmetrical progressive proximal muscle weakness and
was unable to mobilize. At this point, he already had ad-
vanced myopathy.
Initially, the diagnosis of necrotizing myopathy in a pa-
tient with ischemic heart disease and subacute onset of
weakness with a high CK level led to investigation for
drug-induced myopathy. The patient had never taken
statins, proton pump inhibitors, or atypical antipsychotics
that could have myotoxic effects. Of the drugs taken by
the patient, to the best of our knowledge, only amiodarone
is to be considered potentially myotoxic. Besides the more
frequent peripheral neuropathy, amiodarone-associated
myopathy has also been described (review by [13]), in
most cases as a vacuolar autophagic myopathy with type II
fiber atrophy, which was not seen in our patient. Although
amiodarone-induced necrotizing myopathy has been pre-
viously reported, in the present case, peculiar pathological
features, such as MAC capillary deposition and pipestem
capillaries, are not consistent with amiodarone myopathy.
Myotoxicity from salicylates has been reported anecdotally
in one case of chronic abuse. Dermatomyositis may be as-
sociated with MAC deposition in capillaries, usually in a
patchy pattern [6], but was ruled out because of the
Figure 7 Vastus lateralis muscle biopsy. A swollen endothelial
cell of an endomysial capillary, with loss of organelles and
cytoplasmic material. Transmission electron microscopy, ×11,500.
Figure 9 Lung biopsy. Adenocarcinoma with a necrotic
component and surrounding edema. Bronchopneumonia and
emphysema are observed. Hematoxylin and eosin staining, ×25.
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vascular inflammation, and the rather diffuse MAC depos-
ition pattern in capillaries. The pathological pattern also
differed from that of polymyositis because of absence of
significant endomysial infiltrates, lack of lymphohistiocyticFigure 8 Pulmonary hilar lymph node biopsy. Regional
lymphadenopathy (metastases). Hematoxylin and eosin
staining, ×25.invasion of non-necrotic fibers, and mild upregulation of
MHC-I. As NAM has been reported in association with
connective tissue disorders [3,5], and less frequently with
cancer [2,14,15], immunologic and oncologic investigations
were undertaken, leading to the diagnosis of lung cancer.
Paraneoplastic necrotizing myopathies are rare and are
known to be histopathologically heterogeneous, with
myonecrosis ranging from occasional and scattered, to dif-
fuse as in our patient [9]. MAC deposition has been
reported in NAM, both in paraneoplastic [2,14] and non-
neoplastic cases [2,7,14], but it may also be absent [9,14,15].
Capillary loss in association with MAC deposition, as was
observed in our patient, was morphometrically assessed in
one group of cases [14]. Few ultrastructural studies of
microvessels in patients with NAM have been reported
[2-4], and the pathogenic relationship between muscle ne-
crosis and pipestem microangiopathy has yet to be eluci-
dated. A subset of NAM is characterized by anti-SRP
antibodies. SRP is a protein involved in protein trafficking
in endoplasmic reticulum, and anti-SRP antibodies are clas-
sified as myositis-specific autoantibodies [6]. Occasional
cases of paraneoplastic anti-SRP+ NAM have been reported
[14,15]. No association between MAC deposition in capil-
laries and SRP antibodies has been detected, and there are
no distinctive clinicopathological features that differentiate
between SRP+ NAM and SRP– NAM. The role of anti-
SRP antibodies in the pathogenesis of NAM is therefore
unclear. Our patient was not tested for anti-SRP autoanti-
bodies because testing was not available. Polyneuropathy
may also occur in paraneoplastic NAM [14,15], in some
cases associated with previous antiblastic treatment [8].
It is probable that our patient had a mild pre-existing
sensory-motor axonal polyneuropathy, as mild fiber type
grouping consistent with reinnervation was observed. The
moderate upregulation of MHC-I with neoexpression on
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in contrast to the diffuse upregulation observed in poly-
myositis [9,11,14], and a cytokine response inhibiting
upregulation of MHC-I in NAM has been hypothesized.
Conclusion
This case illustrates that paraneoplastic necrotizing myop-
athy should be considered in elderly patients. Because the
pathophysiology of paraneoplastic necrotizing myopathy is
still unclear, there is no standard treatment regimen. Usu-
ally corticoid therapy and/or immunotherapy is suggested,
but treatment of the underlying malignancy is the most
important factor for achieving clinical improvement.
As necrotizing myopathy can worsen the prognosis of
patients with cancer, early diagnosis and treatment are im-
portant. In patients who are unresponsive to corticoste-
roids, immunosuppressive therapy may be used (such as
azathioprine, mycophenolate, methotrexate, or cyclospor-
ine). Intravenous immunoglobulins are used as second-
line therapy [14]. More recently, monoclonal antibodies
such as rituximab have also been used for the treatment of
myopathies including necrotizing myopathy [12].
Consent
Our patient died during hospitalization and his next-of-
kin was not traceable. Despite all reasonable efforts to
find other family members, we were unable to obtain
consent. We believe however that the patient would not
have objected to publication of this case report, that all
data was sufficiently anonymous, and that anyone who
knew the patient would be unable to identify him from
the published article.
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